A- A A+

Our Mission: to be the preeminent professional organization for multiple sclerosis (MS) healthcare providers and researchers in North America, and a valued partner in the global MS community. Our core purpose is to maximize the ability of MS healthcare professionals to impact care of people who are affected by MS, thus improving their quality of life.

 
IJMSC
NARCOMS
IOMSRT
Accredited regional programs are now available from CMSC.  read more...          Article: Running Out Of Time, Money, And Independence? by Michael Ogg  read more...
For a complete list of CMSC materials, please click on the menu below
Please click on the tabs on the left to read about the latest CMSC materials
Archived News



Here are the Archived entries for


In Loving Memory of Hillel Panitch, MD
Wednesday, 29 December 2010
 
CMSC INForMS: Teva Pharmaceutical receives letter from FDA for Glatiramer Acetate sNDA
Wednesday, 29 December 2010
 
CMSC INForMS: Biotech Foundations – Myelin Repair Group Works to Develop Drugs, Cure MS
Wednesday, 29 December 2010
 
National MS Society Leads Way in 2010 in Cutting Edge Research to Stop and End MS Forever
Tuesday, 21 December 2010
 
Article: What You Need to know about Social Security Disability Insurance
Saturday, 18 December 2010
 
Individual Mandate in Healthcare Reform Law Ruled Unconstitutional by Federal Judge
Thursday, 16 December 2010
 
Announcing National MS Society's New Chief Research Officer
Thursday, 16 December 2010
 
CMSC INForMS: Merck Serono and San Raffaele Scientific Institute to Collaborate on Research
Monday, 13 December 2010
 
CMSC INForMS: Teva Announces Successful Results of Phase III Study with Oral Laquinimod for MS
Friday, 10 December 2010
 
CMSC INForMS: Merck Serono Announces Extension of FDA Priority Review Period for Cladribine
Monday, 29 November 2010
 
CMSC INForMS: Multiple Sclerosis Patient Experiences Improved Vision on TYSABRI
Monday, 29 November 2010
 
CMSC INForms : FDA approves Gablofen® (baclofen injection)
Monday, 29 November 2010
 
CMSC INForMS: Merck KGaA – Enrollment Completed for ORACLE MS Study of Cladribine Tablets
Thursday, 18 November 2010
 
CMSC INForMS: Additional Phase 3 Clinical Trial Data on Dalfampridine Extended Release Tablets
Thursday, 18 November 2010
 
CMSC INForMS: Information on new BETASERON (interferon beta - 1b) Injection Syringe
Thursday, 11 November 2010
 
Neurology Reviews Launches MS Comprehensive Care Web site
Tuesday, 02 November 2010
 
CMSC INForMS: FDA Approves Nuedexta™ to Treat Episodes of Uncontrollable Laughing or Crying
Tuesday, 02 November 2010
 
CMSC INForMS: Sanofi-aventis Initiates Phase III Study with Teriflunomide plus Interferon Beta
Friday, 29 October 2010
 
CMSC INForMS: REFLEX Study Show Rebif Treatment Delays MS in Patients with First Signs
Wednesday, 27 October 2010
 
DIME Launches MS Patient Resources iPhone and iPod Touch App
Monday, 25 October 2010
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 1 - 20 of 208